Biotech · Private company
Prove pharm
Track this companyFree. Adds Prove pharm to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- 3,3'-Dioxo-2,2'-bisindolylidene-5,5'-disulfonate disodium 0.8%Phase 3 · Ureter InjuryClinicalTrials.gov · fetched Nov 12, 2026
- Indigotindisulfonate sodium 0.8%Ureter InjuryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal ImpairmentPHASE4 · RECRUITING · started Dec 20, 2023ClinicalTrials.gov NCT06085183 · fetched Nov 12, 2026
- Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral PatencyPHASE4 · COMPLETED · started Oct 12, 2023ClinicalTrials.gov NCT06054880 · fetched Nov 12, 2026
- 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral PatencyPHASE3 · COMPLETED · started Feb 13, 2020ClinicalTrials.gov NCT04228445 · fetched Nov 12, 2026
- Acquired Methemoglobinemia Observational RegistryCOMPLETED · started May 31, 2018ClinicalTrials.gov NCT03542760 · fetched Nov 12, 2026